Category: 3. Business

The UAE’s leadership in digital innovation is entering a new phase. As artificial intelligence accelerates adoption across HR, healthcare and insurance, organisations now have a real opportunity to rethink employee experience, simplify benefits and deliver wellbeing solutions that create measurable value.

AI-enabled tools are reshaping how HR, healthcare and insurance systems connect. One example is the Federal Authority for Government Human Resources, which deployed an AI-powered HR assistant to support more than 50,000 federal employees by automating large volumes of routine HR queries and improving access to services in both English and Arabic.¹

Beyond this, digital identity, automated claims and integrated pharmacy systems are reducing friction across healthcare and insurance processes. These developments are creating smoother, faster interactions across the ecosystem, improving experiences while reducing administrative overhead.

Looking ahead, AI will play a growing role in helping organisations make smarter decisions. Predictive analytics, real-time alerts and intuitive reporting tools are already enabling HR teams to reduce manual effort and focus more on insight-driven action.

Impact on HR and Employee Experience

For employees and employers alike, the benefits from this transformation are becoming increasingly visible in day-to-day interactions.

Employees gain a faster, more transparent, more connected experience of their wellbeing resources. They can monitor the status of approvals or healthcare requests directly via mobile app. They have clear visibility into coverage details, claims status and approval requirements.

For employers, digital-first systems remove many of the administrative burdens that have traditionally created service bottlenecks. Routine insurance and benefits queries no longer require extensive manual handling by HR teams, freeing them to focus on long-term strategy, engagement and organisational culture.

The result is a more empowered, informed and self-sufficient employee base, supported by HR functions that are better positioned to deliver strategic value.

Wellbeing and Insurance in the Digital Age

Digital transformation in HR isn’t only about faster claims or simpler insurance, it’s about expanding the scope of employee benefits to a more holistic view of wellbeing.

Employers can now offer employees genuinely personalised and continuous wellbeing support. Through wearable technology, health apps and digital platforms, employees can track their physical activity, sleep, stress and general health in real time.

Thanks to integrated platforms and data analytics, wellbeing programmes can be tailored to individual needs – offering targeted support rather than generic, one-size-fits-all initiatives. Benefits become more relevant, useful and integrated with daily life.

For employers, this deeper engagement creates better outcomes. Data-driven insight allows organisations to anticipate needs, spot trends and intervene earlier, helping to reduce costs while improving continuity of care and oversight across providers, insurers and regulators.

AI and Future Readiness

If the last few years have been about digitising organisations, the next phase is likely to be about magnifying their intelligence.

AI is no longer a nice-to-have option, it’s a strategic enabler of employer and employee experience. The benefits are real and tangible: automatic, intuitive reports with minimal human input; predictive analytics that forecast claims and wellbeing trends; real-time alerts; strategic personalisation of employee support; and analytics-driven insights into workforce needs.

AI-enabled tools are helping HR teams reduce administrative workload, generate clearer insights and embed smarter decision-making into workforce strategies. Used thoughtfully, technology becomes less about efficiency alone and more about creating meaningful connections between people and the benefits that matter most to them.

Why the UAE Stands Out

Organisations in the UAE are uniquely positioned to lead this transformation. Early government-backed initiatives, such as the National Strategy for Artificial Intelligence 2031, have helped create a strong foundation for widespread adoption across both public and private sectors.²

With established digital infrastructure, AI-friendly policies and integrated platforms, organisations in the UAE can move beyond fragmented solutions toward holistic, data-driven employee experience strategies that deliver real value.

For HR leaders, the message is clear: the time to act is now. By embracing technology and AI with purpose, organisations can build more transparent, resilient and human-centered employee experiences.

Tomorrow starts today. Let’s build a stronger, more resilient workforce together.

¹UAE Government Launches HR AI Agent (opens a new window)

²Dubai’s State of AI Report: The Public Sector Version 2025 (opens a new window)

In the rapid age of artificial intelligence, China has come forward with new rules for AI firms, aiming to protect young minds from online abuse and chatbots that promote self-harm and violence.

Rapid proliferation of chatbots and AI models has been the main driving force behind the planned regulations. Recently, China’s DeepSeek made headlines worldwide as it topped download charts.

Online safety net for children

The draft rules published by the Cyberspace Administration of China (CAC) will focus on measures, aiming to ensure child online safety. The rules will oblige AI companies to offer personalized settings.

The firms would not only impose time limits on usage but also get parental consent before providing emotional companionship services.

Compulsory human-based intervention

The operators will be required to have mandatory human intervention in any chat related to self-harm and suicide. They must notify the user’s guardians in the case of such conversation.

Content moderation

Under the planned proposal, the developers will be responsible for moderate content generation. They must ensure that their model won’t generate any content that promotes gambling and violence .

Responsible use of AI

The regulations would also promote the responsible and ethical use of AI, preventing the sharing of “content that endangers national security, damages national honour and interests [or] undermines national unity.”

Once the regulatory draft is finalized, these rules will be applied to all AI services and products, marking a paradigm shift in efforts to regulate AI bots, which are under fire over safety concerns.

Earlier this week, China also issued new draft rules, aiming to regulate AI with human-like interaction.

The recent move also highlights Beijing’s effort to govern AI and strengthen consumer-oriented safety and ethical requirements.

Charlotte, N.C. — Integrated logistics company A.P. Moller – Maersk (Maersk) is pleased to announce the appointment of Ditlev Blicher as the new Regional President for North America, effective Jan. 1, 2026. Blicher assumes the role after most recently serving as the company’s Regional President for Asia Pacific since 2023.

A logistics industry veteran, Blicher joined Maersk in 2020 with deep global experience in operations and general management. Prior to joining Maersk, he was APA CEO at DB Schenker. He also served as President of Asia Pacific and Europe for Freight Forwarding at UTi Worldwide and Executive Vice President – Group Operations for CEVA Logistics.

Charles van der Steene, who has served as Regional President for North America since January 2024, will become the Managing Director for Maersk’s India, Middle East and African region, where he previously served as Damco’s Regional Managing Director from 2016-2019 before the company merged with Maersk in 2019.

I’m looking forward to working with our talented team in North America to build on the progress they’ve made as we’ve evolved into a full-suite logistics provider. Our focus will be on driving sustainable growth and strengthening operational excellence to deliver a best-in-class experience for our customers.

About Maersk

A.P. Moller – Maersk is an integrated logistics company working to connect and simplify its customers’ supply chains. As a global leader in logistics services, the company operates in more than 130 countries and employs around 100,000 people. Maersk is aiming to reach net zero GHG emissions by 2040 across the entire business with new technologies, new vessels, and reduced GHG emissions fuels*.

*Maersk defines “reduced GHG emissions fuels” as fuels with at least 65% reductions in GHG emissions on a lifecycle basis compared to fossil of 94 g CO2e/MJ.

When the COVID-19 pandemic hit in 2020, Edmonton-based country singer Patrick Masse, like millions of other Canadians, applied for relief benefits.

All the gigs he’d lined up were abruptly cancelled.

“I had really good projected earnings for that year, right? But then everything bottomed out when the world dropped,” said Masse.

From April 2020 to June 2022, Masse received more than $41,000 in government benefits — only to later get a letter from the Canada Revenue Agency saying he wasn’t eligible for the money, and that he had to pay it back.

According to the CRA, Masse did not meet the minimum net earnings of $5,000.

“I was stunned. I couldn’t believe it,” said Masse. “I would have never applied for anything that I did not qualify for.”

In early 2024, after months of back and forth, the CRA agreed he was entitled to some of the money. But he remains on the hook for about $27,000.

“I don’t have the money; I have no money. I live in poverty … I can’t afford to lose $27,000,” said Masse.

He’s far from alone. According to data the CRA provided to CBC News, about $14 billion in COVID-related benefits was given to individuals that the agency says, upon review, didn’t qualify because they didn’t meet the income requirements.

Most of that money was given under the Canadian emergency response benefit (CERB) or Canada recovery benefit (CRB), the latter a $2,000/month payment for those forced to stop working during the pandemic and couldn’t get EI.

In 2022, the CRA begin informing people that a repayment was due. Since then, it’s recouped about $4 billion. But $10 billion is still outstanding.

CRA: Pay up or face legal action

In a statement to CBC News, the CRA said it’s sensitive to the financial pressures facing Canadians but that it will take action against those trying to avoid repayment.

The agency says that could mean legal measures to recover the debt, including “offsetting refunds and future credits and garnishing wages or other sources of income.”

If you owe money to the government, there’s no statute of limitations. You can’t wait out this type of debt.– Brian Mantin, licensed insolvency trustee

Brian Mantin, a licensed insolvency trustee in Vancouver, says he sees clients every week trying to resolve their pandemic repayments. Mantin said the CRA’s approach was initially lenient but “in the last few months, I’ve seen that approach change pretty significantly.”

“So we’re certainly seeing bank account freezes, now we’re seeing garnishes [of pay] … that’s the most painful thing, because that’s when the government’s going directly to your employer and saying, ‘Hey, before the person gets their wages, take 30 per cent off the top,’” said Mantin.

Short of declaring bankruptcy, Mantin said there’s no way of getting around this debt.

“If you owe money to the government, there’s no statute of limitations,” said Mantin. “You can’t wait out this type of debt.”

Taxpayers group demands accountability

The CRA says it gave out approximately $84 billion in COVID-19 benefits to individuals during the pandemic. Franco Terrazzano with the Canadian Taxpayers Federation says that from the get-go, he worried money would go to individuals who didn’t qualify.

Terrazzano says while the government should show compassion to people who have to repay the money, when it comes to those who administered the program, heads should roll.

“I’m talking about the bureaucrats within the government who made these mistakes. Yes, they have to be held accountable,” said Terrazzano. “Look, when you make a multibillion-dollar mess-up, you should be prepared to polish off your resumé.”

Patrick Masse is adamant he was eligible for every dollar he got and plans to fight the repayment for as long as possible. He feels giving the money back would to tantamount to saying he lied on his application — something he’s not prepared to do.

“It’s so brutal. You believe in good faith that you were eligible for that money,” Masse stressed. “I will not admit that I owe this money, because I [applied] in good faith.”

Masse’s perseverance could pay off. As of Nov. 30, the CRA said it had processed about $621 million in reversals for about 55,000 individuals.

The biennial Biologic Therapies Summit took place in Cleveland last spring, but the education continues via webcast through July 9, 2027. The webcasts and continuing medical education credits are free, thanks to the mission that drives the health system’s R.J. Fasenmyer Center for Clinical Immunology at Cleveland Clinic.

“Many meetings across the country have archived virtual materials available, and a number of them broadcast live virtual presentations,” says Leonard Calabrese, DO, Director of the Fasenmyer Center. “We are the only meeting of this type that provides the meeting in person at the lowest cost per credit hour of any national meeting of its kind and also broadcasts it live for free with full CME credit. Our meeting, which has been going on biannually for 25 years, was also one of the first meetings in this educational space to achieve its content virtually for CME credit, absolutely free. Medical education is expensive, and there are many people who are either too busy to travel or find travel to be a financial burden.”

The ability to accomplish these educational goals has been made possible because of philanthropic support of the R. J. Fasenmyer Center of Clinical Immunology, which Dr. Calabrese has led since its inception. Clinical immunologists from areas across the globe are a particular focus among those who benefit, he adds. “We intentionally reach out to rheumatology societies in Europe, Asia, South America and Africa to let them know that this free medical education is available to them.”

The recent conference took place May 8-10, 2025 along with Vasculitis 2025, a separate one-day meeting that focused on emerging care approaches for this family of challenging diseases. New to Biologics this year was a poster session for trainees, who came from across the country. “It’s going to be a fixture at all of our meetings, because it brings along the next generation and allows them to interact with world leaders in the fi eld and receive counsel on their work and their careers,” says Dr. Calabrese.

Since the inception of the Fasenmyer Center, Cleveland Clinic has been dedicated to excellence in immunologic clinical care, research and education. While a variety of educational opportunities are available worldwide that target different audiences and levels of scientific complexity, Cleveland Clinic tailors its immunologic education efforts for “busy clinicians who practice clinical immunology, and with particular reference to rheumatologists, because rheumatologists have the largest spectrum of immune-mediated immunologic diseases,” he says.

Session Lineup

To access CME modules for Biologic Therapies Summit XI, click here.

Plenary Session: Advances In Basic and Translational Immunology for the Clinical Rheumatologist

Learning objectives: Critically appraise and integrate clinical data on the efficacy and toxicity of CAR T-cell therapies, cellular therapies and other advanced treatments to identify and propose strategies that could lead to long-term remission or cure of immune-mediated inflammatory diseases. Evaluate IL-17 inhibitors and IL-23 in treating immune-mediated inflammatory diseases. Explore and interpret the latest advances in IL-23 inhibitors for IMiDs and assess their potential for treating other inflammatory conditions.

Presentations

“Immune Profiling of Patients With Autoimmune Diseases: Defining Metrics of Immune Dysregulation” — Deepak Rao, MD, PhD

“New Insights Into the Role of EBV in Autoimmune Diseases” — William Robinson, MD, PhD

“IL-23 — Advances in Basic and Clinical Immunology” — Christopher Ritchlin, MD, MPH

“The Evolution of Immune Effector Cell Therapies for the Treatment of Autoimmune Diseases” — Maximilian F. Konig, MD

Emerging Treatments in IMiDS

Learning objectives: Describe the process by which “safety signals” emerge. Highlight case studies of where this has gone awry. Recommend solutions for a forward-looking safety agenda. Examine the mechanism of action of JAK inhibitors in modulating immune responses and identify the potential toxicities and adverse effects, particularly infection risks. Critically evaluate emerging therapeutic strategies for difficult-to-treat psoriatic arthritis, rheumatoid arthritis,
systemic lupus erythematosus and inflammatory myopathies, and propose innovative approaches to optimize patient outcomes based on current advancements.

Presentations

“Signal and the Noise: Safety in Rheumatology” — Michael Putman, MD, MSci “PsA” — Christopher Ritchlin, MD, MPH
“Difficult to Treat RA (D2TRA)” — Jack Cush, MD
“Emerging Treatments in Lupus Nephritis” — Michelle Petri, MD, MPH
“Advances in the Treatment of Inflammatory Myopathies” — Rohit Aggarwal, MD, MS

Developments in the Prevention and Treatment of Complications From Advanced Therapies

Learning objectives: Investigate and differentiate between infectious complications from biologic therapies and immune-related adverse events associated with checkpoint inhibitor therapies while formulating effective prevention and management strategies.

Presentations

“Infectious Complications From Biologic Therapy” — Cassandra Calabrese, DO
“Immune-Related Adverse Events From Checkpoint Inhibitor Therapy: Targeted Therapies” — Noha Abdelwahab Hassan, MD, PhD
“Moneyball Rheumatology – Making the Most Out of Our Time and Data for Better Care of Our Patients” — Jack Cush, MD